Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation

Mesenchymal stem cells (MSCs), due to their potential for differentiation into alveolar epithelial cells and their immunosuppressive characteristics, are considered a new therapeutic agent in cell-based therapy of inflammatory lung disorders, including chronic obstructive pulmonary disease (COPD). S...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrell, Carl Randall, Miloradovic, Dragica, Sadikot, Ruxana, Fellabaum, Crissy, Markovic, Bojana Simovic, Miloradovic, Dragana, Acovic, Aleksandar, Djonov, Valentin, Arsenijevic, Nebojsa, Volarevic, Vladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109559/
https://www.ncbi.nlm.nih.gov/pubmed/32257769
http://dx.doi.org/10.1155/2020/3153891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109559/
https://www.ncbi.nlm.nih.gov/pubmed/32257769
http://dx.doi.org/10.1155/2020/3153891

Ejemplares similares